Spaces are limited, please do book early to avoid disappointment.
at any stage of the journey, looking to confidently answer VIVA questions on unfamiliar or diverse products
supporting trainee QPs, seeking to strengthen application success
wanting to broaden their knowledge and CPD in a shifting manufacturing environment
whose organisations are expanding into new formulation types
The QP conference is a full-day event featuring a series of invited talks, panel sessions, interactive workshops and networking opportunities.
| Time | Item |
| 08:45 | Registration and Coffee |
| 09:15 | Welcome and Introduction to RSSL Emily Ness |
| 09:30 | Role and Duties of a QP in a Diverse and Changing Manufacturing Environment Peter Deegan |
| 10:00 | Investigational Medicinal Products (IMP) Clinical Supply Speaker TBC |
| 10:20 | Specials Manufacture Speaker TBC |
| 10:40 | Inhalation Devices Steve Nolan |
| 11:00 | Coffee and Networking |
| 11:20 | Workshop: QP Scenarios (Sessions 2-4) |
| 11:45 | Cell and Gene Therapy/Biologics Rebecca Rutter |
| 12:05 | Decentralised Manufacturing Model Peter Deegan and Ben Broadbent |
| 12:45 | Lunch and Networking |
| 13:45 | The Progression and Pitfalls of AI in Pharma Martin Lush |
| 14:05 | Radiopharmaceuticals TBC |
| 14:40 | ICH E6 Revision 3: Clinical Trial Guidance Updates Peter Deegan |
| 15:00 | Coffee and Networking |
| 15:20 | Interactive Workshop: Novel Formulation Knowledge Peter Deegan and Presenters |
| 16:00 | Regulatory Update MHRA Speaker TBC |
| 16:20 | Closing Remarks and Q&A |
| 16:30 | End of Conference |
Peter is an experienced Pharmaceutical QA professional, with over 30 years GMP, ISO 9001 Quality Systems, audit and training experience.
A Chemistry Graduate, Peter started his career in QC laboratories for a small generics company, before joining ICI (now AstraZeneca) in 1992, where he held QA positions and obtained his Qualified Person status in 1995. He subsequently led a global training organisation for several years, worked in R&D QA and Regulatory Affairs and became Quality Lead for major outsourcing programmes to India and Japan. Peter has experience across a wide range of dosage forms and has a specialism in Pharmaceutical Quality Systems.
Peter established his own consultancy in October 2015, after 23 years with AstraZeneca. He is an active, highly experienced international auditor and has ISO 9001 Pharmaceutical Lead Auditor status. Peter was keynote speaker at the 2015 IRCA Japan symposium on how Pharma has incorporated ISO 9001 into its modern Quality Systems.
Rebecca has more than 25 years' experience in the pharmaceutical industry focussing on IMPs in clinical trials, ATMPs and the transfer of products into commercial production.
She is a C suite capable pharmaceutical quality professional specialising in setting up and running greenfield manufacturing facilities, systems, processes, supply chain and achieving strategic business milestones.
Rebecca’s success stems from her unique combined expertise in both direct manufacturing operations and GMP quality regulatory compliance. This translates to proven achievements (three greenfield sites set up and two decommissioned) seeing the bigger picture to identify and mitigate risks.
With a broad spectrum of auditing complex global supply chains and developing Quality Management and Risk Management Systems, Rebeccahelps organisations as evolve and improve.
Steve is a highly experienced Pharmaceutical Quality professional with over 20 years in GMP-regulated environments, spanning Quality Assurance, Quality Control, and Qualified Person responsibilities. He has held senior leadership roles including Head of Quality and Quality Director, as well as operating as a consultant across a wide range of pharmaceutical organisations. Steve specialises in the design, implementation, and continuous improvement of Pharmaceutical Quality Systems across research, clinical, and commercial manufacturing environments.
He has extensive experience across diverse dosage forms—including sterile and aseptic products, biologics, inhalation therapies, radiopharmaceuticals, and solid dose forms—and has a strong track record of engaging with global regulatory authorities, leading inspections, and delivering successful remediation programmes. As an eligible Qualified Person, Steve brings deep expertise in product release, supply chain oversight, and compliance with EU directives.
Steve is also an accomplished auditor and advisor, having assessed numerous organisations across the pharmaceutical supply chain against GMP, GCP, GLP, and ISO standards.
